Showing 1 - 6 results of 6 for search 'INTRO-HCV Study Group', query time: 0.04s Refine Results
  1. 1
    Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020

    Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020 by Jørn Henrik Vold, Rolf Gjestad, Christer F. Aas, Eivind Meland, Kjell Arne Johansson, Lars Thore Fadnes, for the INTRO-HCV Study Group

    Published 2021-03-01
    Get full text
    Article
  2. 2
    Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study

    Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study by Karl Trygve Druckrey-Fiskaaen, Jørn Henrik Vold, Tesfaye Madebo, Håvard Midgard, Olav Dalgard, Rafael Alexander Leiva, Lars T. Fadnes, for the INTRO-HCV Study Group

    Published 2024-03-01
    Get full text
    Article
  3. 3
    Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway

    Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway by Ole Jørgen Lygren, Ronny Bjørnestad, Else-Marie Løberg, Martine Lepsøy Bonnier, Vibeke Bråthen Buljovcic, Kjell Arne Johansson, Lars T. Fadnes, for the INTRO-HCV Study Group

    Published 2019-12-01
    Get full text
    Article
  4. 4
    Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020

    Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020 by Jørn Henrik Vold, Rolf Gjestad, Christer F. Aas, Fatemeh Chalabianloo, Svetlana Skurtveit, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes, for the INTRO-HCV Study Group

    Published 2020-12-01
    Get full text
    Article
  5. 5
    Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV).

    Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV). by Lars T Fadnes, Christer Frode Aas, Jørn Henrik Vold, Rafael Alexander Leiva, Christian Ohldieck, Fatemeh Chalabianloo, Svetlana Skurtveit, Ole Jørgen Lygren, Olav Dalgård, Peter Vickerman, Håvard Midgard, Else-Marie Løberg, Kjell Arne Johansson, INTRO-HCV Study Group

    Published 2021-06-01
    Get full text
    Article
  6. 6
    Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)

    Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV) by Lars T. Fadnes, Christer Frode Aas, Jørn Henrik Vold, Christian Ohldieck, Rafael Alexander Leiva, Fatemeh Chalabianloo, Svetlana Skurtveit, Ole Jørgen Lygren, Olav Dalgård, Peter Vickerman, Håvard Midgard, Else-Marie Løberg, Kjell Arne Johansson, for the INTRO-HCV Study Group

    Published 2019-11-01
    Get full text
    Article

Search Tools: